EVOKE PHARMA, INC. Long-Term Debt, Maturity, Year Three
EVOKE PHARMA, INC. had Long-Term Debt, Maturity, Year Three of $2.12 million as of 2015-12-31, per its 10-K filed 2016-03-10.
Discontinued › Notes › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2016-03-10
- 2015-12-31: Long-Term Debt, Maturity, Year Three $2.12M.
- 2014-12-31: Long-Term Debt, Maturity, Year Three $2.12M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2015-12-31 | $2.12M 10-K · filed 2016-03-10 |
| 2014-12-31 | $2.12M 10-K · filed 2015-03-04 |